Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants
JAMA · 2024
DOI: 10.1001/jama.2023.24527 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Kai Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming, China. Hauptthemen laut MEDLINE: Infant, Premature, Pulmonary Surfactants, Surface-Active Agents. Die Arbeit nennt 5 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
To the Editor A recent 2-year follow-up study1 compared the effect of minimally invasive surfactant therapy (MIST) vs control (placebo) on neurodevelopment disability and death at 2 years’ corrected age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming, China.
- National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Zitieren
APA
Liu, K., & Shi, Y. (2024). Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants. JAMA. https://doi.org/10.1001/jama.2023.24527
Vancouver
Liu K, Shi Y. Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants. JAMA. 2024. doi:10.1001/jama.2023.24527
BibTeX
@article{Liu2024,
author = {Liu, Kai and Shi, Yuan},
title = {Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2023.24527}
}
EUVIMED